Convalescent Plasma Therapy Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Convalescent Plasma Therapy Market By 2029?

The convalescent plasma therapy market has experienced swift expansion in recent years. Its projected growth trajectory indicates an increase from $0.05 billion in 2024 to $0.06 billion in 2025, advancing at a compound annual growth rate (CAGR) of 11.1%. Historically, the market’s expansion can be ascribed to elements such as pandemics and infectious disease outbreaks, ongoing immunotherapy research, the implementation of emergency use authorization (eua), enhanced patient availability, and a rise in clinician and public awareness.

The convalescent plasma therapy market is anticipated to experience substantial growth in the upcoming years, with projections indicating an increase to $0.09 billion by 2029, achieving a compound annual growth rate (CAGR) of 13.6%. This expansion during the forecast period is primarily fueled by factors such as the emergence of evolving pathogens, progress in immunotherapies development, supportive regulatory frameworks, global preparedness efforts, and various public health initiatives. Significant trends expected in this period encompass standardized collection and processing methods, the development of targeted plasma components, personalized treatment approaches, the integration of telemedicine and remote monitoring, and ongoing research into the long-term effects of the therapy.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

Which Drivers Are Shaping The Convalescent Plasma Therapy Industry’s Market Share?

The enhanced efficacy and safety demonstrated during trials for CPT in COVID-19 patients are expected to drive market growth throughout the forecast period. Convalescent plasma transfusion has historically been a topic of interest for managing other infectious disease outbreaks, including SARS‐1, Middle East Respiratory Syndrome (MERS), and 2009 H1N1. In June 2022, research conducted by the Houston Methodist hospital, focusing on the safety and efficacy of COVID-19 convalescent plasma therapy, revealed that the therapy is safe, reporting no adverse events, and efficient, with a 76% recovery rate. A study published in the Journal of Medical Virology in May 2020 further indicated that convalescent plasma therapy could potentially reduce the mortality rate in critically ill patients, lead to beneficial effects on clinical symptoms, and result in an increase in neutralizing antibody titers and the disappearance of SARS‐CoV‐2 RNA. The proven safety and efficacy of convalescent plasma therapy in COVID-19 patients are poised to boost the global convalescent plasma therapy market growth.

What Are The Segment Types Shaping The Convalescent Plasma Therapy Market?

The convalescent plasma therapymarket covered in this report is segmented –

1) By Antibody type: IgM; IgG; IgA

2) By Application: Prophylaxis; Treatment

3) By End-Users: Hospitals And Clinics; Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma; Acute Phase Plasma; Other IgM-Based Plasma Products

2) By IgG: High Titer IgG Plasma; Standard IgG Plasma; Other IgG-Based Plasma Products

3) By IgA: Plasma Rich In IgA; Specific IgA Antibody Plasma; Other IgA-Based Plasma Products

What Trends Are Redefining The Convalescent Plasma Therapy Market Dynamics?

The emergence of antibody-based immunotherapy as a potential therapeutic solution for COVID-19 presents opportunities for the convalescent plasma therapy market. Convalescent plasma therapy functions by using antibodies produced against coronavirus by a donor to improve the recipient’s immunity. Companies are launching trials, forming collaborations, and investing in antibody-based COVID-19 therapy. For instance, in August 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, partnered with the Biomedical Advanced Research and Development Authority (BARDA) to assist with the clinical development, clinical manufacturing, and regulatory licensure processes for next-generation COVID-19 monoclonal antibody therapy, aimed at preventing SARS-CoV-2 infection. This collaboration is part of Project NextGen, an initiative by the U.S. Department of Health and Human Services (HHS) to establish a pipeline of advanced COVID-19 vaccines and therapies. As per the project’s design, Regeneron will independently develop and propose an antibody candidate, which BARDA and Regeneron will then assess and select for further research, manufacturing, and regulatory efforts. Given that convalescent plasma therapy utilizes antibodies, the increasing focus on antibody-based COVID-19 therapy is anticipated to boost market growth.

Which Leading Players Are Enhancing Their Convalescent Plasma Therapy Market Presence Worldwide?

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

What Regional Growth Trends Are Shaping The Convalescent Plasma Therapy Market Outlook?

North America was the largest region in the convalescent plasma therapy market in 2024. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Convalescent Plasma Therapy Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp

Browse Through More Reports Similar to the Global Convalescent Plasma Therapy Market 2025, By The Business Research Company

Plasmas Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Plasma Fractionation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Porcine Plasma Feed Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/porcine-plasma-feed-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795